GTH - Genetron Holdings Ltd

0   0%

Share volume: 0
Last Updated:
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 18%
Dept financing 0%
Liquidity 0%
Performance 45%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
N/A
P/E Ratio 
N/A
DAY RANGE
N/A - N/A
EPS 
N/A
52 WEEK RANGE
N/A - N/A
52 WEEK CHANGE
N/A
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Si Z. Wang
Region: US
Website: genetronhealth.com
Employees: 1,150
IPO year: 2020
Issue type:
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Genetron Holdings Limited engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay.

Recent news